|
⚲
|
| Keyboard |
| Haas Kevin
✚
|
|
|---|---|
| CIK # | 0001723780 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001723780] | |
| 4 | [0001723780] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Haas Kevin | |
| Vincerx Pharma Inc | |
| Aravive Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aravive Inc ARAV
Stock Option · derivative
|
2019-02-28 | Grant | 18,000 | $0.00 | |
|
Aravive Inc ARAV
Common Stock
|
2019-02-01 | Sell | 63 | $4.14 | 261 |
|
Aravive Inc ARAV
Common Stock
|
2019-02-01 | Sell | 141 | $4.14 | 584 |
|
Aravive Inc ARAV
Common Stock
|
2018-12-21 | Sell | 686 | $3.22 | 2,209 |
|
Aravive Inc ARAV
Common Stock
|
2018-12-21 | Sell | 25 | $3.23 | 81 |
|
Aravive Inc ARAV
Common Stock
|
2018-12-17 | Sell | 1,164 | $3.96 | 4,609 |
|
Aravive Inc VSAR
Common Stock
|
2018-06-15 | Sell | 143 | $2.30 | 329 |
|
Aravive Inc VSAR
Common Stock
|
2018-02-08 | Sell | 1,599 | $1.80 | 2,878 |
|
Aravive Inc VSAR
Common Stock
|
2017-12-20 | Grant | 44,700 | $0.00 |